Hematopoietic and endothelial differentiation of human induced pluripotent stem cells
- PMID: 19259936
- PMCID: PMC2931800
- DOI: 10.1634/stemcells.2008-0922
Hematopoietic and endothelial differentiation of human induced pluripotent stem cells
Abstract
Induced pluripotent stem cells (iPSCs) provide an unprecedented opportunity for modeling of human diseases in vitro, as well as for developing novel approaches for regenerative therapy based on immunologically compatible cells. In this study, we employed an OP9 differentiation system to characterize the hematopoietic and endothelial differentiation potential of seven human iPSC lines obtained from human fetal, neonatal, and adult fibroblasts through reprogramming with POU5F1, SOX2, NANOG, and LIN28 and compared it with the differentiation potential of five human embryonic stem cell lines (hESC, H1, H7, H9, H13, and H14). Similar to hESCs, all iPSCs generated CD34(+)CD43(+) hematopoietic progenitors and CD31(+)CD43(-) endothelial cells in coculture with OP9. When cultured in semisolid media in the presence of hematopoietic growth factors, iPSC-derived primitive blood cells formed all types of hematopoietic colonies, including GEMM colony-forming cells. Human induced pluripotent cells (hiPSCs)-derived CD43(+) cells could be separated into the following phenotypically defined subsets of primitive hematopoietic cells: CD43(+)CD235a(+)CD41a(+/-) (erythro-megakaryopoietic), lin(-)CD34(+)CD43(+)CD45(-) (multipotent), and lin(-)CD34(+)CD43(+)CD45(+) (myeloid-skewed) cells. Although we observed some variations in the efficiency of hematopoietic differentiation between different hiPSCs, the pattern of differentiation was very similar in all seven tested lines obtained through reprogramming of human fetal, neonatal, or adult fibroblasts with three or four genes. Although several issues remain to be resolved before iPSC-derived blood cells can be administered to humans for therapeutic purposes, patient-specific iPSCs can already be used for characterization of mechanisms of blood diseases and for identification of molecules that can correct affected genetic networks.
Figures
Similar articles
-
Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures.Blood. 2006 Sep 15;108(6):2095-105. doi: 10.1182/blood-2006-02-003327. Epub 2006 Jun 6. Blood. 2006. PMID: 16757688 Free PMC article.
-
Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors.J Clin Invest. 2009 Sep;119(9):2818-29. doi: 10.1172/JCI38591. Epub 2009 Aug 10. J Clin Invest. 2009. PMID: 19726877 Free PMC article.
-
Role of SOX17 in hematopoietic development from human embryonic stem cells.Blood. 2013 Jan 17;121(3):447-58. doi: 10.1182/blood-2012-05-431403. Epub 2012 Nov 20. Blood. 2013. PMID: 23169777
-
Evolution of induced pluripotent stem cell technology.Curr Opin Hematol. 2010 Jul;17(4):276-80. doi: 10.1097/MOH.0b013e328339f2ee. Curr Opin Hematol. 2010. PMID: 20442654 Review.
-
Deciphering the hierarchy of angiohematopoietic progenitors from human pluripotent stem cells.Cell Cycle. 2013 Mar 1;12(5):720-7. doi: 10.4161/cc.23823. Epub 2013 Feb 6. Cell Cycle. 2013. PMID: 23388453 Free PMC article. Review.
Cited by
-
Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients.Blood. 2013 Aug 8;122(6):912-21. doi: 10.1182/blood-2013-01-478321. Epub 2013 Jun 6. Blood. 2013. PMID: 23744582 Free PMC article.
-
Engineered Tissue Patch for Cardiac Cell Therapy.Curr Treat Options Cardiovasc Med. 2015 Aug;17(8):399. doi: 10.1007/s11936-015-0399-5. Curr Treat Options Cardiovasc Med. 2015. PMID: 26122908 Free PMC article.
-
Induced pluripotent stem cell-derived vascular smooth muscle cells.Vasc Biol. 2019 Dec 12;2(1):R1-R15. doi: 10.1530/VB-19-0028. eCollection 2020. Vasc Biol. 2019. PMID: 32923972 Free PMC article. Review.
-
Vascular tissue engineering: biodegradable scaffold platforms to promote angiogenesis.Stem Cell Res Ther. 2013 Jan 24;4(1):8. doi: 10.1186/scrt156. Stem Cell Res Ther. 2013. PMID: 23347554 Free PMC article. Review.
-
Generating human hematopoietic stem cells in vitro -exploring endothelial to hematopoietic transition as a portal for stemness acquisition.FEBS Lett. 2016 Nov;590(22):4126-4143. doi: 10.1002/1873-3468.12283. Epub 2016 Jul 22. FEBS Lett. 2016. PMID: 27391301 Free PMC article. Review.
References
-
- Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676. Epub 2006 Aug 2010. - PubMed
-
- Maherali N, Sridharan R, Xie W, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell. 2007;1:55–70. - PubMed
-
- Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448:313–317. Epub 2007 Jun 2006. - PubMed
-
- Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007;448:318–324. Epub 2007 Jun 2006. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous